Vanguard Group’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $41.5M | Buy |
|
|||||
|
2025
Q2 | $50.9M | Buy |
|
|||||
|
2025
Q1 | $52.5M | Buy |
|
|||||
|
2024
Q4 | $81.9M | Buy |
|
|||||
|
2024
Q3 | $90.1M | Buy |
|
|||||
|
2024
Q2 | $75.7M | Buy |
|
|||||
|
2024
Q1 | $38M | Sell |
|
|||||
|
2023
Q4 | $26.8M | Sell |
|
|||||
|
2023
Q3 | $21.3M | Buy |
|
|||||
|
2023
Q2 | $26.9M | Buy |
|
|||||
|
2023
Q1 | $23.3M | Buy |
|
|||||
|
2022
Q4 | $24.2M | Buy |
|
|||||
|
2022
Q3 | $28.2M | Buy |
|
|||||
|
2022
Q2 | $26.8M | Buy |
|
|||||
|
2022
Q1 | $28.4M | Buy |
|
|||||
|
2021
Q4 | $57.6M | Buy |
|
|||||
|
2021
Q3 | $59.3M | Buy |
|
|||||
|
2021
Q2 | $38.9M | Buy |
|
|||||
|
2021
Q1 | $36.2M | Buy |
|
|||||
|
2020
Q4 | $20.3M | Buy |
|
|||||
|
2020
Q3 | $18.7M | Buy |
|